OPPORTUNITY RESEARCH

Exciting Sponsored Microcap Research

Innovative BioPharma Set for Major Re-Valuation in 2023

OKYO Pharma Limited (NASDAQ: OKYO) just commenced a Phase II clinical trial...

Transformed GRIL Set for Record Growth

Muscle Maker, Inc. (NASDAQ: GRIL) is set to grow revenue from $162M in 2022...

Pending Merger Could Drive NYSE Player's Market Cap Higher

The Camber Energy, Inc. (NYSE: CEI) pending merger with Viking Energy Group...

Undervalued, Underfollowed, High Growth MedTech Firm Offers Major Upside

In what may be the best kept secret on Wall Street, emerging MedTech Firm H...

This 41% CAGR Stock Set for New Highs

Charlie's Holdings, Inc. (OTCQB: CHUC), a leader in its underlying space ap...

view more sponsored research

SPECIAL REPORTS

Timely Market & Sector Reports

TOP 23 PREDICTIONS FOR 2023

We welcome you to enjoy our Top 23 Predictions for 2023

TOP 20 PREDICTIONS FOR 2020

We welcome you to enjoy our Top 20 Predictions for 2020

TOP 19 PREDICTIONS FOR 2019

Welcome to our annual top predictions in economics, the market, politics, sports, and pop culture.

TOP 17 PREDICTIONS FOR 2017

We had great predictions and picks for 2016. See what lies ahead for 2017.

Our 6th Annual Special Thanksgiving...

It is that time of year again. Welcome to our 6th Annual Thanksgiving Treats & Turkeys Report....

view all

The Goldman Guide

Don't Sell in May and Go Away

In this text-only issue of The Goldman Guide, see what types of stocks we recommend selling AND buying. Also, interestin...

How ETFs are Changing the Investing Landscape

ETFs are getting bigger and better and diverse. How they are being used, when they are being used and the significance o...

The Goldman Guide: A Short-Term Investing Trick

In this week's edition we teach how cause/effect investing can be profitable short term, and also provide critical marke...

view all

YouTube

Our Latest Videos
	FAANG Stocks and a Great Biotech - The Goldman Guide 5 February 2023
	Where is the Market Headed Now? The Goldman Guide 16 January 2023

Facebook

@GoldmanSmallCap

GoldmanSmallCap New report on $OKYO w/$5.50 price target. Upcoming milestones to drive major re-valuation of stock in 2023 and poss… https://t.co/DvvnqM2sfp

May 09 • reply • retweet • favorite

GoldmanSmallCap New rept on $GRIL w/conservative $4.50 target in 6-9 mos. Enviable transformative situation. Investors will be hung… https://t.co/jsBU3C9aj4

May 05 • reply • retweet • favorite

GoldmanSmallCap New report out on $ORHB w/price target. Best kept secret on Wall Street. Undervalued, underfollowed medtech provide… https://t.co/Bx8guoh5Tn

Apr 20 • reply • retweet • favorite

GoldmanSmallCap New report on $CHUC w/near term price tgt more than 3x closing price. Huge top-line growth ahead, and strong op inc… https://t.co/ppIlkhBtZI

Apr 13 • reply • retweet • favorite

GoldmanSmallCap New report on $CEI w/price target. Pending merger with $VKIN a long time coming but all legacy news shown in underv… https://t.co/OqCI2KnbSr

Mar 28 • reply • retweet • favorite